# YAZ Premenstrual Dysphoric Disorder (PMDD) in China

> **NCT00824187** · PHASE3 · COMPLETED · sponsor: **Bayer** · enrollment: 187 (actual)

## Conditions studied

- Premenstrual Dysphoric Disorder ( PMDD)

## Interventions

- **DRUG:** EE20/DRSP(YAZ, BAY86-5300)
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00824187
- **Lead sponsor:** Bayer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-01
- **Primary completion:** 2011-01
- **Final completion:** 2011-01
- **Target enrollment:** 187 (ACTUAL)
- **Last updated:** 2014-04-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00824187

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00824187, "YAZ Premenstrual Dysphoric Disorder (PMDD) in China". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT00824187. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*